Contents of Volume 2, Supplement 1

Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas
Shrigley Hall Hotel, Manchester, UK. 28 – 30 May 2002
Edited by Michael J Brown

This review is part of a collection of working papers first presented at the Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas, held between 28 – 30 May 2002 at Shrigley Hall Hotel, Manchester, UK. The meeting was sponsored by the Mectizan® Donation Program, Merck & Co. Inc., and GlaxoSmithKline and was kindly hosted by the Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine.

Editorial
Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas
Brian OL Duke
Filaria Journal 2003, 2(Suppl 1):S1 (24 October 2003)

Meeting Report
Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas
Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas
Filaria Journal 2003, 2(Suppl 1):S2 (24 October 2003)

Review
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases
Nana AY Twum-Danso
Filaria Journal 2003, 2(Suppl 1):S3 (24 October 2003)

Review
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon
Michel Boussinesq, Jacques Gardon, Nathalie Gardon-Wendel, Jean-Philippe Chippaux
Filaria Journal 2003, 2(Suppl 1):S4 (24 October 2003)

Review
Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients
Charles D Mackenzie, Timothy G Geary, John A Gerlach
Filaria Journal 2003, 2(Suppl 1):S5 (24 October 2003)

Review
Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
Kwablah Awadzi
Filaria Journal 2003, 2(Suppl 1):S6 (24 October 2003)

Review
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future
Nana AY Twum-Danso
Filaria Journal 2003, 2(Suppl 1):S7 (24 October 2003)

Review
Ivermectin: does P-glycoprotein play a role in neurotoxicity?
Geoffrey Edwards
Filaria Journal 2003, 2(Suppl 1):S8 (24 October 2003)

Review
A Framework for Decision-Making for Mass Distribution of Mectizan® in Areas Endemic for Loa loa
David G Addiss, Richard Rheingans, Nana AY Twum-Danso, Frank O Richards
Filaria Journal 2003, 2(Suppl 1):S9 (24 October 2003)

Review
Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis
Nancy J Haselow, Julie Akame, Cyrille Evini, Serge Akongo
Filaria Journal 2003, 2(Suppl 1):S10 (24 October 2003)